In recent years, the medical field has expanded its arsenal against erectile dysfunction (ED), introducing novel agents like avanafil. This PDE5 inhibitor has captured attention for its rapid onset and minimal side effects. Another agent, Cialis Super Active, has carved out a niche, with its enhanced formulation promising increased efficacy. Both medications serve distinct purposes …